In a retrospective RCT subgroup analysis, showing no survival benefit of anti-TNFα Ab CB0006 in 80 unselected severe sepsis patients, the patients with increased entry TNF-levels appeared to benefit from the high dose anti-TNF Ab (survival rate 86%, n = 7) [17]. Here, TNF is linked to Sepsis.